NVIDIA CORP (NVDA)       221.73  +10.84 (+5.14%)

221.73  +10.84 (+5.14%)

US67066G1040 - Common Stock - After market: 223.31 +1.58 (+0.71%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NVDA. NVDA was compared to 106 industry peers in the Semiconductors & Semiconductor Equipment industry. NVDA has a medium financial health rating, its profitability is only medium as well. While showing a medium growth rate, NVDA is valued expensive at the moment.




Profitability

Profitability Rating

5

NVDA has a Return On Assets of 14.71%. This is better than the industry average of 11.42%.
NVDA has a Return On Equity of 27.90%. This is better than the industry average of 19.73%.

NVDA has a Profit Margin of 20.85%. This is comparable to the industry average of 18.09%.
The Piotroski-F score of NVDA is 6.00. This is a neutral score and indicates average health and profitability for NVDA.
VS Industry

ROA (14.71%) VS Industry: 62% outperformed.

0.20
34.75

ROE (27.9%) VS Industry: 70% outperformed.

1.44
136.01

Profit Margin (20.85%) VS Industry: 58% outperformed.

0.27
57.04

Valuation

Valuation Rating

1

The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The Price/Earnings Ratio is 58.81, which means the current valuation is very expensive for NVDA.
With a Price/Earning Ratio of 58.81, NVDA is valued a higher than the industry average, which is at 16.42. 88% of the companies listed in the same industry are cheaper than NVDA!
With a Forward Price/Earnings Ratio of 50.35, NVDA is valued very expensively.

With a price book ratio of 25.55, NVDA is valued rather expensively.
When comparing the price book ratio of NVDA to the average industry price book ratio of 3.78, NVDA is valued more expensive than its industry peers. 96% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of NVDA to the average industry ratio of 11.86, NVDA is valued more expensive than its industry peers. 90% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (58.81) VS Industry: 12% outperformed.

597.22
2.05

Price/Book (25.55) VS Industry: 4% outperformed.

1,621.79
0.49

Enterprise Value/ EBITDA (58.07) VS Industry: 10% outperformed.

1,666.11
0.04

Growth

Growth Rating

5

The Earnings Per Share has been growing by 47.35% on average over the past 5 years. This is a very strong growth
Looking at the last year, NVDA shows a quite strong growth in Revenue. The Revenue has grown by 17.68% in the last year.
The Revenue has been growing by 31.25% on average over the past 5 years. This is a very strong growth!
The Revenue is expected to grow by 13.23% on average over the next 5 years. This is quite good.

The earnings per share for NVDA have decreased by -3.33% in the last year.
Based on estimates for the next 5 years, NVDA will show a small growth in Earnings Per Share. The EPS will grow by 9.94% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS47.35% 38.93% -3.33% -25.14% -0.47% 8.63% 9.94%
Revenue31.25% 31.95% 17.68% 0.96% 4.99% 10.65% 13.23%

Health

Health Rating

6

A Current Ratio of 3.39 indicates that NVDA has no problem at all paying its short term obligations.
NVDA has a Quick Ratio of 2.74. This indicates that NVDA is financially healthy and has no problem in meeting its short term obligations.
An Altman-Z score of 18.39 indicates that NVDA is not in any danger for bankruptcy at the moment.
The Altman-Z score of NVDA is much better than the industry average of 4.69. NVDA has a better rating than 86% of its industry peers.

NVDA has a Current Ratio comparable to the industry average, which is at 3.15.
The Quick Ratio is in line with the industry averages, which is at 2.35.
The Piotroski-F score of NVDA is 6.00. This is a neutral score and indicates average health and profitability for NVDA.
Compared to an average industry Debt to Equity Ratio of 0.18, NVDA is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.45) VS Industry: 30% outperformed.

135.78
0.00

Quick Ratio (2.74) VS Industry: 55% outperformed.

0.32
20.10

Current Ratio (3.39) VS Industry: 52% outperformed.

0.46
20.10

Altman-Z (18.39) VS Industry: 86% outperformed.

-62.19
94.91

Dividend

Dividend Rating

4

6.73% of the earnings are spent on dividend by NVDA. This is a low number and sustainable payout ratio.
NVDA has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NVDA has a limited annual growth rate of 1.61%.
With a yearly dividend of 0.09%, NVDA is not a good candidate for dividend investing.

With a Dividend Yield of 0.09, NVDA pays less dividend than the industry average, which is at 1.75. 100% of the companies listed in the same industry pay a better dividend than NVDA!
With a Dividend Yield of 0.09, NVDA pays less dividend than the S&P500 average, which is at 2.42.
NVDA's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (0.09%) VS Industry: 0% outperformed.

0.09
18.20

NVIDIA CORP221.73

NASDAQ:NVDA (2/7/2023, 7:00:03 PM)+10.84 (+5.14%)

After market: 223.31 +1.58 (+0.71%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Semiconductors & Semiconductor Equipment
GICS Industry Semiconductors & Semiconductor Equipment
Earnings (Last) 11-16 2022-11-16/amc Earnings (Next) 02-14 2023-02-14/amc
Inst Owners 62.79% Inst Owner Change -1.61%
Ins Owners 0.43% Ins Owner Change 29.82%
Market Cap 545.46B Analysts 78.37
Price Target 199.64 (-9.96%)

Dividend
Industry RankSector Rank
Dividend Yield 0.09%
Dividend Growth(5Y) 1.61% DP 6.73%
Div Incr Years N/A Div Non Decr Years 10
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -39.14%
Min EPS beat(2) -60.17% Max EPS beat(2) -18.11%
EPS beat(4) 2 Avg EPS beat(4) -17.33%
Min EPS beat(4) -60.17% Max EPS beat(4) 5.87%
Revenue beat(2) 1 Avg Revenue beat(2) -9.06%
Min Revenue beat(2) -18.88% Max Revenue beat(2) 0.76%
Revenue beat(4) 3 Avg Revenue beat(4) -4.25%
Min Revenue beat(4) -18.88% Max Revenue beat(4) 0.99%
PT rev (1m) -0.05% PT rev (3m) 2.74%
EPS NQ rev (1m) 5.28% EPS NQ rev (3m) 4.92%
EPS NY rev (1m) 0% EPS NY rev (3m) -2.8%
Revenue NQ rev (1m) -1.91% Revenue NQ rev (3m) -2.17%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.28%

Valuation
Industry RankSector Rank
PE 58.81
Fwd PE 50.35
P/S 19.09
P/FCF 112.95
P/OCF 84.88
P/B 25.55
P/tB 36.06
EV/EBITDA 58.07
EPS(TTM) 3.77 EY 1.7%
EPS(NY) 4.4 Fwd EY 1.99%
FCF(TTM) 1.96 FCFY 0.89%
OCF(TTM) 2.61 OCFY 1.18%
SpS 11.61 BVpS 8.68
TBVpS 6.15 PEG (NY) N/A
PEG (5Y) 1.24

Profitability
Industry RankSector Rank
ROA 14.71%
ROE 27.9%
ROIC 17.13%
ROICexc 28.11%
ROICexgc 40.37%
OM 25.52%
PM 20.85%
GM 57.84%
ROICexgc(3y) 59.73% ROICexcg growth 3Y -5.04%
ROICexcg growth 5Y -25.4% ROICexc(3y) 39.32%
ROICexc growth 3Y -13.69% ROICexc growth 5Y -18.99%
OM growth 3Y 4.74% OM growth 5Y 5.88%
PM growth 3Y 0.83% PM growth 5Y 8.49%
GM growth 3Y 1.99% GM growth 5Y 2%
F-Score 6 Asset Turnover 0.71

Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.27
Debt/EBITDA 1.26
Cap/Depr 111.91%
Profit Quality 81.06%
Current Ratio 3.39
Quick Ratio 2.74
Altman-Z 18.39
F-Score 6 WACC 11.19%
ROIC/WACC 3.61 Cap/Depr(3y) 104.74%
Cap/Depr(5y) 168.24% Profit Quality(3y) 114.85%
Profit Quality(5y) 103.18%

Growth
EPS 1Y -3.33% EPS 3Y 38.93%
EPS 5Y 47.35% EPS growth Q2Q -50.43%
EPS Next Y -25.14% EPS Next 2Y -0.47%
EPS Next 3Y 8.63% EPS Next 5Y 9.94%
Revenue growth 1Y 17.68% Revenue growth 3Y 31.95%
Revenue growth 5Y 31.25% Revenue growth Q2Q -16.5%
Revenue Next Year 0.96% Revenue Next 2Y 4.99%
Revenue Next 3Y 10.65% Revenue Next 5Y 13.23%
EBIT growth 1Y -15% EBIT growth 3Y 38.2%
EBIT growth 5Y 38.97% EBIT Next Year -16.58%
EBIT Next 3Y 11.58% EBIT Next 5Y 10.97%
FCF growth 1Y 14.16% FCF growth 3Y 37.28%
FCF growth 5Y 40.3% OCF growth 1Y 23.1%
OCF growth 3Y 34.5% OCF growth 5Y 40.36%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA